Leverage Shares PLC Leverage Shares - Intraday Rebalance 3x MRNA

RNS Number : 0116E

Leverage Shares PLC

12 September 2024

 

 

Leverage Shares plc

 

 

12.09.2024

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF THE HOLDERS OF THE ETP SECURITIES. IF ANY ETP SECURITYHOLDER IS IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS IMMEDIATELY

If you have recently sold or otherwise transferred your entire holding(s) of ETP Securities referred to below, you should immediately forward this document to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

NOTICE OF INTRADAY REBALANCE

Leverage Shares plc (the ("Issuer") hereby gives notice that at 09:30:16 EST on 12.09.2024 (the "Trigger Time"), the price of Moderna Inc. (MRNA) (the "Reference Asset") for the Leverage Shares 3x Long Moderna (MRNA) ETP (ISIN: XS2675718725) (the "ETP Securities") reached a trading price of $66.24 on exchange (the "Trigger Value"), representing a drop of -16.69% from its previous closing price of $79.51, thereby crossing the -16.67% set in the index methodology for the iSTOXX Leveraged 3x MRNA Index (the "Index").

 

This event triggered an intraday rebalance of the Index, which in turn triggered an intraday rebalance of the ETP Securities as provided in the Prospectuses for the ETP Securities:

https://leverageshares.com/?page_id=16700

 

https://leverageshares.com/?page_id=16514

 

(the "Prospectuses").

Starting 5 minutes after the Trigger Time, the Issuer carried out an intraday rebalance over the 10-minute period following the Trigger Time using the Trigger Value as the reference (the "Intraday Rebalance"), achieving an average price of $65.58074 and setting an ETP Security Value of $1.21191 (the "Rebalanced ETP Security Value").

 

Terms used but not defined in this notice shall bear the meanings assigned to them in the Prospectuses.

 

If you have any queries arising from this notice, please contact us at [e-mail].

 

Yours sincerely

 

 

 

 

The Directors

Leverage Shares plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCSFFFLEELSESU